InvestorsHub Logo
Followers 5
Posts 239
Boards Moderated 0
Alias Born 05/23/2013

Re: None

Thursday, 06/22/2023 3:18:45 PM

Thursday, June 22, 2023 3:18:45 PM

Post# of 325
Only other comparable company on the same Phase 3 trial is FibroGen Inc with a market cap over $1.1 billion.

A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer
https://classic.clinicaltrials.gov/ct2/show/NCT04229004
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCY News